Melanoma Vaccines
Findings advance knowledge in melanoma vaccines research
Published in Vaccine Weekly, March 23rd, 2005
Study 1: B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A exhibit reduced tumorigenicity.
According to a study from Canada, "Immunotherapy based on the administration of the mycobacterium bacillus Calmette-Guerin has been successfully used in the treatment of in situ transitional cell bladder cancer, and may be applicable to the treatment of cutaneous malignant melanoma. Antigen 85A (Ag85A) and heat shock protein 65 kDa (hsp65) are major secreted proteins of Mycobacterium species and potent stimulators of cell-mediated immunity....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-03-23)
More Articles from Vaccine Weekly
- Atherosclerosis Vaccine
Immunomodulation of atherosclerosis reviewed - HIV/AIDS Vaccine
Antibodies to HIV vif turns HIV infection into benign problem - Human Papillomavirus Vaccine
Human papillomavirus oncoprotein vaccine eradicates established tumors - Influenza Vaccine
Immunostimulant patch improves response to influenza vaccine in elderly - Measles Vaccine
Measles genotype in Spain after measles elimination plan reported - Adverse Drug Reaction
U.S. FDA approves i.v. immune globulin for adverse reactions to smallpox vaccine - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
